AI assistant
ABBOTT LABORATORIES — Director's Dealing 2018
Feb 22, 2018
29777_dirs_2018-02-21_9843a613-b9d1-4056-af4a-52e0f3e73ebb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2018-02-16
Reporting Person: Fussell Stephen R (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-16 | Common shares without par value | A | 44909 | — | Acquired | 184884 | Direct |
| 2018-02-20 | Common shares without par value | M | 104642 | $38.40 | Acquired | 289526 | Direct |
| 2018-02-20 | Common shares without par value | S | 1100 | $59.47 | Disposed | 288426 | Direct |
| 2018-02-20 | Common shares without par value | S | 300 | $59.48 | Disposed | 288126 | Direct |
| 2018-02-20 | Common shares without par value | S | 1419 | $59.49 | Disposed | 286707 | Direct |
| 2018-02-20 | Common shares without par value | S | 441 | $59.495 | Disposed | 286266 | Direct |
| 2018-02-20 | Common shares without par value | S | 1200 | $59.50 | Disposed | 285066 | Direct |
| 2018-02-20 | Common shares without par value | S | 1172 | $59.51 | Disposed | 283894 | Direct |
| 2018-02-20 | Common shares without par value | S | 200 | $59.515 | Disposed | 283694 | Direct |
| 2018-02-20 | Common shares without par value | S | 728 | $59.52 | Disposed | 282966 | Direct |
| 2018-02-20 | Common shares without par value | S | 989 | $59.53 | Disposed | 281977 | Direct |
| 2018-02-20 | Common shares without par value | S | 226 | $59.54 | Disposed | 281751 | Direct |
| 2018-02-20 | Common shares without par value | S | 574 | $59.545 | Disposed | 281177 | Direct |
| 2018-02-20 | Common shares without par value | S | 180 | $59.56 | Disposed | 280997 | Direct |
| 2018-02-20 | Common shares without par value | S | 500 | $59.58 | Disposed | 280497 | Direct |
| 2018-02-20 | Common shares without par value | S | 500 | $59.585 | Disposed | 279997 | Direct |
| 2018-02-20 | Common shares without par value | S | 500 | $59.59 | Disposed | 279497 | Direct |
| 2018-02-20 | Common shares without par value | S | 100 | $59.595 | Disposed | 279397 | Direct |
| 2018-02-20 | Common shares without par value | S | 22500 | $59.60 | Disposed | 256897 | Direct |
| 2018-02-20 | Common shares without par value | S | 1600 | $59.63 | Disposed | 255297 | Direct |
| 2018-02-20 | Common shares without par value | S | 500 | $59.635 | Disposed | 254797 | Direct |
| 2018-02-20 | Common shares without par value | S | 1700 | $59.64 | Disposed | 253097 | Direct |
| 2018-02-20 | Common shares without par value | S | 600 | $59.645 | Disposed | 252497 | Direct |
| 2018-02-20 | Common shares without par value | S | 4794 | $59.65 | Disposed | 247703 | Direct |
| 2018-02-20 | Common shares without par value | S | 3200 | $59.655 | Disposed | 244503 | Direct |
| 2018-02-20 | Common shares without par value | S | 10 | $59.6575 | Disposed | 244493 | Direct |
| 2018-02-20 | Common shares without par value | S | 8206 | $59.66 | Disposed | 236287 | Direct |
| 2018-02-20 | Common shares without par value | S | 2985 | $59.665 | Disposed | 233302 | Direct |
| 2018-02-20 | Common shares without par value | S | 77 | $59.668 | Disposed | 233225 | Direct |
| 2018-02-20 | Common shares without par value | S | 100 | $59.669 | Disposed | 233125 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-16 | Option (right to buy) | $59.94 | A | 246963 | Acquired | 2028-02-15 | Common shares (246963) | Direct |
| 2018-02-20 | Option (right to buy) | $38.40 | M | 104642 | Disposed | 2026-02-18 | Common shares (104642) | Direct |
Footnotes
F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
F2: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 82,321 on 02/16/2019, 82,321 on 02/16/2020, and 82,321 on 02/16/2021.
F3: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.